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The World Summit of Harmonization on Traditional, Alternative and Complementary Medi-
cine (TACM) was held in Lima, Peru, November 7–11, 2007, with almost 600 worldwide
participants. This meeting was organized by Peruvian Medical College, the institution that
affiliates and authorizes all physicians to practice medicine in Peru. The meeting included seven
sections starting with an overview on the current status of the TACM. The second section
included experiences from different countries on regulations and quality control in products and
services used in the TACM. The worldwide experience of education and training in TACM was
a very important part of the meeting in which speakers from Spain, Germany, Argentina, Italy,
Brazil, Cuba and Peru shared their experience. The meeting included topics on homeopathy,
acupuncture, mind–body medicine, neural therapy, chiropraxis, among others. Two final
sessions were related to the ways of linking Traditional medicine to the national Health Systems
in the Latin America countries and also the association between bio-commerce and TACM
including intellectual properties and bio-piracy.
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The World Summit of Harmonization on Traditional,
Alternative and Complementary Medicine (TACM) was
held in Lima, Peru, November 7–11, 2007. A welcome
message was delivered by Dr Xiaouri Zhang, Director
from the TACM program at the World Health Organiza-
tion (WHO). This meeting was organized by Peruvian
Medical College, the institution that affiliates and
authorizes all physicians to practice medicine in Peru.
Peru is a classical example in which traditional medi-
cine is broadly used since ancient times. This is revealed
in many papers in the scientific literature showing the use
of traditional medicine in particular with medicinal plants
in the coast (1–6), the Andean region (7–10) and the
Amazonian (9–21).
Peru has also contributed with several natural resources
used as food, like potato or for treating diseases.
For instance, the Cinchona tree—Cinchona calisaya—
has provided quinine, a product that was used in the past
to treat malaria (22,23). Quinine, an alkaloid derived
from the bark of the cinchona tree was brought to
Europe from Peru in the 17th century. Isolation of quinine
and other cinchona alkaloids was achieved in France in
the early part of the 19th century and uncertainties
of supply of the bark stimulated efforts to synthesize qui-
nine (23). Actually many Peruvian plants have been asses-
sed to important health problems as tuberculosis (24,25),
inflammatory diseases (26) and cancer (9,27).
The use of TACM has expanded broadly in the world,
and this has been recognized by WHO. However, the
indiscriminate, sometimes irresponsible or non-regulated
use of several alternative therapeutic methods put in risk
the health of the population using these medicines (14).
For such reason a worldwide consensus is needed for
harmonization in research, training and regulation of
TACM. Then, based on this, the Peruvian Medical Col-
lege organized the world summit in order to gather and
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where regulations of TACM are more developed.
The meeting included seven sections starting with an
overview on the current status of the TACM. The second
section included experiences from different countries on
regulations and quality control in products and services
used in the TACM. The worldwide experience of edu-
cation and training in TACM was a very important part
of the meeting in which speakers from Spain, Germany,
Argentina, Italy, Brazil, Cuba and Peru shared their
experience. In the University of Zaragoza, Spain, TACM
teaching is observed at the School of Medicine, School of
Nursing and in Postgraduate programs. In Germany,
university teaching of TACM started in the late seventies.
Argentina is working to promote the incorporation of
TACM in the curriculum of Medical School. In the
Medical Faculty of the State University of Milan a
postgraduate course on TACM exists since 1993. In
Campinas, Brazil, research and seminars on TACM are
additionally offered to students of different careers. In
Camaguey, Cuba, teaching in TACM is formal in post-
graduate courses and as specialty for physicians. In Peru
at the San Marcos University, a program on TACM is
performed since 2001.
An important component for the traditional medicine is
the scientific demonstration that properties claimed for
different therapeutic methods are valid. Then, this world
summit included three sessions based on scientific evidence
in TACM, clinical applications of TACM and proposal for
criteria and methodologies in TACM research. Experts
from France, Germany, Ecuador, Venezuela, Colombia,
China, United States and Peru contributed to these
sessions. One significant contribution was from Edwin
Cooper, distinguished Professor from the Laboratory of
Comparative Neuroimmunology, University of California,
USA. Prof. Cooper demonstrated that TACM when rigo-
rous can be science (28). Another topic of interest was
presented by Dr Carmen Tamayo (Venezuela/USA) whose
presentation was oriented to new methods and challenges
when searching for evidence in TCAM. Finally in this
session, Dr Gustavo Gonzales presented a model of sci-
entific development with a natural Peruvian product
currently under intense investigation.
It is known that traditional medicine not only deals
with the knowledge and application of medicinal plants,
but with a variety of strategies traditionally developed
with the purpose to obtain the human well-being; thus,
the meeting included topics on homeopathy, acupuncture,
mind–body medicine, neural therapy, chiropraxis, among
others. It is important to distinguish what does Tradi-
tional medicine means. In contemporary Western medi-
cine ‘traditional medicine’ meant to refer to the Western
medical tradition, whereas ‘non-traditional medicine’
encompasses both ‘complementary’ and ‘alternative’
medical practices. Complementary medicine complements
conventional medical treatments, and alternative modes
of medical interventions are meant to replace traditional
Western medicine. Evidence-based research must be
directed at establishing the best available evidence in
complementary and alternative medicine (29). For each
country, there is a traditional medicine. When this medi-
cine is used in another places are considered as ‘comp-
lementary’ or ‘alternative’. The importance of TACM has
emphasized in four excellent articles from Olalde Rangel
(30–33).
Two final sessions were related to the ways of linking
Traditional medicine to the National Health Systems in
the Latin America countries and also the association
between bio-commerce and TACM including intellectual
properties and bio-piracy. The first was co-ordinated by
the Andean Organism of Health in charge of Dr Oscar
Feo (Venezuela). In Brazil, TACM is incorporated in the
Primary Health Care. The current diagnosis and trends of
TACM in Colombia was made in 2006. This will serve as
reference by policy-makers, stake-holders, administrators
and users. In Chile, TACM has been gradually incorpo-
rated in the last years through the Ministry of Health. In
Mexico, TACM has been fully incorporated into the
Mexican Constitution, General Law of Health and in the
National health Plans 2007–12.
The best poster was awarded to Celine Valadeau et al.
in a collaborative study from the Institute of Research
for Development (IRD), France, the Universidad Nacio-
nal Mayor de San Marcos (Lima, Peru) and the com-
munity of San Peter in Pichanaz (Oxapampa, Peru).
Ethno medicinal information from 600 plants from the
central jungle in Peru close to the Andean region was
recorded. It is an interesting fact that Traditional medicine
in this population shares characteristics from the Trad-
itional medicine in the Andean and Amazonian regions.
In conclusion, this meeting was successful since more
than 600 people—most of them with medical degree—
attended the meeting, with great interaction between
audience and speakers. The Peruvian Traditional Medi-
cine is recognized since the Peruvian Medical College
created the Committee of TACM in 2006, headed by
Dr Martha Villar, a physician recognized by her expertise
in traditional medicine. The Committee is also comprised
of Rosario Rojas, Jose ´ Luis Aguilar, Carlos Corbacho,
GustavoFGonzales, Ciro Maguin ˜ a, Hugo Malaspina and
Oscar Villavicencio. The wide traditional use of medicinal
plants is also recognized in Peru, however, there is still
a lack of reliable scientific data (2,5,7–11,13,15,17,18,
25–27). This may produce situations in which products
with long tradition can be commercialized for uses
completely different from the original traditional use.
The importance of scientific research to demonstrate
properties from medicinal plants is recognized. One
example is the Peruvian Andean plant Lepidium meyenii
(Maca) cultivated for longer than 1000 years in the
highlands of Peru, which is appreciated by its nutritional,
energizer and fertility-enhancing properties (9). This plant
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century. Despite of the long time of cultivation and that
traditional knowledge on its properties was written since
XVII century (9), the first scientific publication in a peer
review journal on biological property of maca appeared
in 2000 (34), and more than 20 Peruvian studies on Maca
have been published in international journals from 2001
up to date (9,35,36,37). From 1999 to 2001, there was
observed a reduction in the production and exportation
of maca. However, since the dates of the scientific publi-
cations, production of maca increased over time up to
2007 (35).
The necessity of including traditional medicine in the
programs of the medical schools, to increase research and
publications were raised during the discussion of the
World Summit.
It is important to note that several congresses with a
characteristic of this world summit have been developed
worldwide during the last decade. This is important
because it allows to increase the knowledge on evidence
generation for CAM. One important issue is to maintain
the sustainability of these meetings. For such reason, the
next step will be to build an international network for
continuously met and evaluate advances in TCAM in
different countries. Next meeting will be held in Brazil
in 2009.
As end part of the meeting, a Declaration was deve-
loped with several recommendations.
Declaration of Lima
The participants, governmental representatives, universi-
ties, related institutions and the civil society, heralding
from more than 20 countries of Europe, Asia and
America, met in the city of Lima, Peru during the
World Summit for Harmonization of TACM, organized
by the Peruvian Medical Association (CMP). Following a
number of presentations and deliberations in different
aspects, features and subjects of TACM, with the objec-
tive of informing governmental authorities and the global
scientific community the group decided to summarize the
conclusions of the meeting in the following ‘Declaration
of Lima’.
Considering
 that, traditional medicine is used by a great part of
the world population, and it is accepted that the
development of new therapeutic alternatives based
on traditional medicine knowledge are needed, then,
it is necessary to look for the harmonization of both
conventional and traditional medicine approaches,
with the purpose of improving Public Health
worldwide;
 that, in the last decades, the practice and use of
TACM has increased exponentially, having been rec-
ognized officially by the WHO as a form of medicine
extensively used by the world population and with
great possibilities of offering cost-effective alterna-
tives for public health;
 that, the indiscriminate, irresponsible and unregu-
lated use of diverse alternative and complementary
therapeutic methods may lead to public-health risks
and on the other hand, may also discredit an ances-
tral form of medicine with demonstrated effective-
ness and relevance, when adequately used;
 that, TACM requires greater consensus in its organ-
ization, investigation, configuration and regulation
and that it is necessary to appropriately integrate
these aspects within the health care sector, involving
the general population and urging the governments
to be actively involved and change policies and
strategies to improve health care;
 that, the benefits of the current health care systems,
mainly based on conventional (Western) medicine,
only reach a limited percentage of the population
and since the resources assigned by the governments,
especially in developing countries, are insufficient to
cover health care expenses, it is necessary to har-
monize and integrate both systems of medicine with
their respective strengths: TACM in the promotion
of healthy life styles, disease prevention and low-cost
therapeutic interventions directed to diseases or con-
ditions of low complexity, and conventional medi-
cine in the solution of acute problems or diseases of
higher complexity.
It is recommended:
(1) to acknowledge the existence of different models
and medical systems and address the importance of
studying their ‘Cosmo vision’, especially in the case
of Traditional Medicine that should be better stud-
ied, investigated, valued, respected and promoted;
(2) to increase participation of all sectors in society. In
health care, it is utterly important to have the parti-
cipation of the government, citizens and health care
communities, and all should actively contribute to
the social process of health–disease;
(3) to acknowledge the existence of different health and
health-care paradigms that, when articulated or
joined in their common characteristics will allow a
better understanding of the human being and the
process of health–disease;
(4) to promote the articulation within the official sys-
tems of public health in each country, of TACM
systems in order to improve the quality of life of
their population, particularly because of the wide-
spread use of TACM worldwide;
(5) to urge the Governments to assign greater resources
and technical support for the expansion of their
eCAM 2010;7(2) 273national systems of health, in order to integrate
TACM and obtain a unique, cost-effective, popula-
tion-based health care system;
(6) to promote the development and harmonization of
the directives necessary for the implementation of
the integration and articulation of TACM in each
country, considering, formation of human resources,
improvement in quality control and safety of
products as well as increasing funds for research
and endorsement;
(7) to sensitize and spread TACM knowledge among
different sectors: health care managers, community,
research and academic institutions and health pro-
fessionals, through a variety of activities such as
forums, symposiums, congresses and workshops; as
well as to share experiences with countries around
the world through exchange networks;
(8) to urge Universities and other academic institutions
to include in its undergraduate and graduate cur-
riculum the teaching of TACM and the validation
of its knowledge and practices through research and
pertinent activities;
(9) to be permanently alert, so that traditional knowl-
edge and therapeutic natural resources are not the
object of illegal appropriation, biopiracy or patent
traffic, and to stimulate their recognition as a
national patrimony and its fair economic value to
the communities that use and preserve them;
(10) to promote that the processes of management,
development, systematization and education of
Traditional Medicine are carried out by those
having recognition of their communities, supported
by the government, the universities and the civil
society. In that sense, respect to the environment, to
the tangible and intangible resources of traditional
Medicine, to the traditional knowledge and to its
practitioners should be promoted;
(11) to develop and promote new approaches and
methods of investigation and to implement strategies
to obtain financial resources and train professionals
that will contribute to the research, development
and implementation of TACM;
(12) to promote the adequate, responsible and ethical use
of TACM, avoiding illegal or fraudulent use and
promote the dialogue between both conventional
medicine and TACM practitioners in order to
exchange knowledge and improve health care;
(13) to guarantee the continuity of similar TACM World
Summits. An agreement was reached to organize
and held biannual meetings in countries from dif-
ferent continents, designating Brazil as the venue for
the next TACM World Summit to be held in 2009.
An effort will be made to increase participation of
government, academic and research institutions as
well as regulators, scientists and practitioners from
all over the world;
(14) to design adequate mechanisms that allow the
diffusion, distribution, follow-up, evaluation and
accomplishment of the recommendations of the
‘Declaration of Lima’.
The present Declaration is signed, to substantiate the
agreement reached by citizens interested in improving the
health of the world population and the commitment to
work in order that each point of this declaration is
considered and implemented in the countries of the three
continents represented.
Lima, November 11, 2007
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